title: Combination of hormone therapy with sartan: an option for hypertensive postmenopausal women?
authors.forename: Alfred O
authors.initials: AO
authors.lastname: Mueck
authors.forename: Harald
authors.initials: H
authors.lastname: Seeger
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001713:Biphenyl Compounds / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000077405:Irbesartan; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000008:administration & dosage*; D014664:Vasodilation / Q000187:drug effects
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D004958:Estradiol; D000077405:Irbesartan